Premier Perspectives The blog for insider insights in clinical development COVID-19 COVID-19 & Clinical Trials: Direct-to-Patient Model Keeps Research Moving and Patients Safe By Victoria Watts April 7, 2020 Featured Posts Global Compliance Data Protection Part 3: Key Considerations for Clinical Trial Recruitment By Victoria Watts March 13, 2019 Global Compliance Data Protection Part 2: Ensuring Study Start-Up Compliance With GDPR By Victoria Watts March 6, 2019 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Data Protection Part 1: Understanding How GDPR Affects Clinical Trials By Victoria Watts February 12, 2019 × ALSO OF INTERESTGene Therapy 101: From the 1960s to TodayNostalgia or Shell Shock? Assessing PTSD Is a...Designing Pediatric Analgesic Treatment...
